A5036776518- Lymphoma Diagnosis and Treatment
- Eosinophilic Esophagitis
- Acute Myeloid Leukemia Research
- Pneumocystis jirovecii pneumonia detection and treatment
- Antibiotic Resistance in Bacteria
- Eosinophilic Disorders and Syndromes
- Acute Lymphoblastic Leukemia research
- Lymphadenopathy Diagnosis and Analysis
- Urticaria and Related Conditions
- T-cell and Retrovirus Studies
- Cutaneous lymphoproliferative disorders research
- Chronic Lymphocytic Leukemia Research
- Genetic factors in colorectal cancer
- Immune Cell Function and Interaction
- Cytomegalovirus and herpesvirus research
- Hematopoietic Stem Cell Transplantation
- CAR-T cell therapy research
- Antibiotics Pharmacokinetics and Efficacy
- Renal and related cancers
Université Libre de Bruxelles
2019-2024
Erasmus Hospital
2019-2023
Universitair Ziekenhuis Brussel
2020
Biologie Labor
2020
Since nucleoside-modified mRNA vaccines strongly activate T follicular helper cells, it is important to explore the possible impact of approved SARS-CoV-2 on neoplasms affecting this cell type. Herein, we report and discuss unexpected rapid progression lymphomatous lesions after administration a BNT162b2 vaccine booster in man recently diagnosed with AITL.
We aimed to compare the efficacy of ceftazidime-avibactam (CAZ-AVI) versus best available therapy (BAT) in solid organ transplant (SOT) recipients with bloodstream infection caused by carbapenemase-producing Klebsiella pneumoniae (CPKP-BSI). A retrospective (2016-2021) observational cohort study was performed 14 INCREMENT-SOT centers (ClinicalTrials.gov identifier: NCT02852902; Impact Specific Antimicrobials and MIC Values on Outcome Bloodstream Infections Due ESBL- or...
With the improvement of treatment methods in acute hematology malignancies, development sensitive tools for minimal residual disease assessment has become a priority. The monitoring WT1 expression level by real-time quantitative PCR been standard evaluation myeloid leukemia and, since 2009, optimized through European LeukemiaNet effort an established protocol with well-defined clinical end points. Building on work LeukemiaNet, this article reports novel, one-step duplex WT1/ABL1 droplet...
Since nucleoside-modified mRNA vaccines strongly activate T follicular helper cells, it is important to explore the possible impact of approved SARS-CoV-2 on neoplasms affecting this cell type. Herein, we report and discuss unexpected rapid progression lymphomatous lesions after administration a BNT162b2 vaccine booster in man recently diagnosed with AITL.